Replies to post #309141 on Amarin Corp Plc (AMRN)

[circuitcity]

I agree that a double digit is not a far fetch target from here.

What is the ticker for below?
Quote:
I have seen stocks at $4 get bought out at $18 about 6 weeks later,

[postes]

Oneragman...stocks with drugs in phase trials sell at a higher premium.

There is nothing that AMRN has done to give any BP confidence..There is no guarantee the uptake on V will be what JT says...AMRN may never be profitable...ceo are accountable (not JT ) AmRn did not sell after R_IT or during .....they are not selling now.

It is oncology that BP is mostly chasing.

[zmanindc]

Exactly.....
Owning this stock and living through all the ups, downs and missteps is worse than being a Mets fan. There has to be a special place in heaven for Amarin shareholders. For management, and express elevator to hell!

Can’t blame them for the difficult sales environment under COVID but they take responsibility for signing off on the 9th circuit and not going after Covington for malpractice.

They could also set out a reasonable US strategy to help analysts value the stock. They should be more aggressive promoting V as a possible therapeutic for COVID. You think Remdesivir just popped up without Gilead out there making the drug available and promoting its properties.

My other huge problem with these idiots, no other partners or regulatory filings for the 50 or so countries that could benefit from the drug and add value to the sales model.